Skip to main content
TipRanks
Go Ultimate75% OFF

Mebuki Financial Group, Inc. (7167) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

7167 Analyst Ratings

Currently, no data available

7167 Stock 12 Month Forecast

There Are No Analyst Ratings for 7167 In The Last 3 Months.

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for JP:7167
Price TargetArticle
TipRanks - PerPlexity¥1,565buy4.47%UpsideReiterated11/10/26
TipRanks - Google¥1,588buy6.01%UpsideReiterated11/10/26
TipRanks - Anthropic¥1,478hold-1.34%DownsideReiterated11/10/26
TipRanks - OpenAI¥1,485hold-0.87%DownsideReiterated11/10/26
TipRanks - DeepSeek¥1,547buy3.27%UpsideReiterated11/10/26
TipRanks - xAI¥1,568buy4.67%UpsideReiterated11/10/26
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Mebuki Financial Group, Inc.

3 Months
PerPlexity Banks - Regional JP
PerPlexity Banks - Regional JPTipRanks - PerPlexity
Success Rate0/2 ratings generated profit
0%
Average Return
-9.40%

Copying PerPlexity Banks - Regional JP's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -9.40% per trade.

1 Year
PerPlexity Banks - Regional JP
PerPlexity Banks - Regional JPTipRanks - PerPlexity
Success Rate0/2 ratings generated profit
0%
Average Return
-9.40%

Copying PerPlexity Banks - Regional JP's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -9.40% per trade.

2 Years
PerPlexity Banks - Regional JP
PerPlexity Banks - Regional JPTipRanks - PerPlexity
Success Rate0/2 ratings generated profit
0%
Average Return
-9.40%

Copying PerPlexity Banks - Regional JP's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -9.40% per trade.

7167 Analyst Recommendation Trends

00.511.52Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for 7167
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy00000
Buy00000
Hold00000
Sell00000
Strong Sell00000
total00000

In the current month, 7167 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 7167 average Analyst price target in the past 3 months is ―.

7167 Financial Forecast

¥19¥23.5¥28¥32.5¥37Q4 2025Q2 2026Q3 2026
High¥30.74
Consensus¥30.74
Low¥30.74

7167 Earnings Forecast

Next quarter’s earnings estimate for 7167 is JPY 30.74 with a range of JPY 30.74 to JPY 30.74. The previous quarter’s EPS was JPY 26.35. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.

¥93.9B¥96.8B¥99.8B¥102.7B¥105.6BQ4 2025Q2 2026Q3 2026
Consensus¥106B

7167 Sales Forecast

Next quarter’s sales forecast for 7167 is JPY 105.64B with a range of ― to ―. The previous quarter’s sales results were JPY 105.64B. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.

7167 Stock Forecast FAQ

Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Mebuki Financial Group, Inc.?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Mebuki Financial Group, Inc.?
To buy shares of JP:7167, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.